Evaluating Cascade Communication Methods

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 19, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
BRCA1 MutationBRCA2 Mutation
Interventions
BEHAVIORAL

Disclosure Toolkit

"Participants will receive a Disclosure Toolkit consisting of a family letter, gene information chatbot, and informational website to aid in communicating their genetic test results with at-risk relatives."

Trial Locations (1)

19104

Abramson Cancer Center, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER